相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism
A. E. Kopytova et al.
PARKINSONISM & RELATED DISORDERS (2021)
Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases
Margarita Ivanova
JOURNAL OF CLINICAL MEDICINE (2020)
Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
Tae-Un Han et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1
M. Judith Peterschmitt et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Biomedical Implications of Autophagy in Macromolecule Storage Disorders
Adina Maria Palhegyi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases
Margarita M. Ivanova et al.
PLOS ONE (2019)
Effect of Ambroxol chaperone therapy on Glucosylsphingosine (Lyso-Gb1) levels in two Canadian patients with type 3 Gaucher disease
Behshad Charkhand et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2019)
Mitochondrial membrane potential
Ljubava D. Zorova et al.
ANALYTICAL BIOCHEMISTRY (2018)
Small fluorescent molecules for monitoring autophagic flux
Hidefumi Iwashita et al.
FEBS LETTERS (2018)
Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons
J. Magalhaes et al.
SCIENTIFIC REPORTS (2018)
Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey
Ida Vanessa D. Schwartz et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2018)
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Jerome Stirnemann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Glucosylceramide synthase regulates the proliferation and apoptosis of liver cells in vitro by Bcl-2/Bax pathway
Jun-Feng Li et al.
MOLECULAR MEDICINE REPORTS (2017)
The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease
Kerri J. Kinghorn et al.
NEURAL REGENERATION RESEARCH (2017)
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models
S. Pablo Sardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
Anna Migdalska-Richards et al.
SYNAPSE (2017)
A novel algorithm identifies stress-induced alterations in mitochondrial connectivity and inner membrane structure from confocal images
Mathieu Ouellet et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Neuronal Mitophagy in Neurodegenerative Diseases
Marta Martinez-Vicente
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease
Maria J. Perez et al.
FRONTIERS IN NEUROSCIENCE (2017)
Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy
Timothy M. Cox et al.
BLOOD (2017)
Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease
Joana Magalhaes et al.
HUMAN MOLECULAR GENETICS (2016)
A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin
Kerri J. Kinghorn et al.
JOURNAL OF NEUROSCIENCE (2016)
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
Aya Narita et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Quantitative analysis of mitochondrial morphology and membrane potential in living cells using high-content imaging, machine learning, and morphological binning
Anthony P. Leonard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca2+ release from acidic Ca2+ stores
Giorgio Fois et al.
CELL CALCIUM (2015)
Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells
Ola Awad et al.
HUMAN MOLECULAR GENETICS (2015)
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells
Giulia Ambrosi et al.
NEUROBIOLOGY OF DISEASE (2015)
Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy
Elena V. Pavlova et al.
JOURNAL OF PATHOLOGY (2015)
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
Alisdair McNeill et al.
BRAIN (2014)
Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration
Tamar Farfel-Becker et al.
HUMAN MOLECULAR GENETICS (2014)
inhibition of glucosyleramide synthase stimulates autophagy flux in neutrons
Wei Shen et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Automated Quantification and Integrative Analysis of 2D and 3D Mitochondrial Shape and Network Properties
Julie Nikolaisen et al.
PLOS ONE (2014)
Gaucher iPSC-Derived Macrophages Produce Elevated Levels of Inflammatory Mediators and Serve as a New Platform for Therapeutic Development
Leelamma M. Panicker et al.
STEM CELLS (2014)
Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease
Ari Zimran et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
Inna Bendikov-Bar et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice
Zhuo Luan et al.
BRAIN & DEVELOPMENT (2013)
Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease-Links to Parkinson's Disease
Laura D. Osellame et al.
CELL METABOLISM (2013)
Neuronal autophagy and neurodegenerative diseases
Jin H. Son et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
The role of saposin C in Gaucher disease
Rafael J. Tamargo et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Primary Skin Fibroblasts as a Model of Parkinson's Disease
Georg Auburger et al.
MOLECULAR NEUROBIOLOGY (2012)
Mitochondrial Dysfunction in Skin Fibroblasts from a Parkinson's Disease Patient with an alpha-Synuclein Triplication
Sally K. Mak et al.
JOURNAL OF PARKINSONS DISEASE (2011)
Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting
Anna M. Vaccaro et al.
HUMAN MOLECULAR GENETICS (2010)
Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits
Ying Sun et al.
HUMAN MOLECULAR GENETICS (2010)
Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
Giancarlo Parenti
EMBO MOLECULAR MEDICINE (2009)
Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
Gustavo H. B. Maegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Optimization and Validation of Two Miniaturized Glucocerebrosidase Enzyme Assays for High Throughput Screening
Daniel J. Urban et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2008)
Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis
David Halter et al.
JOURNAL OF CELL BIOLOGY (2007)
Three classes of gluclocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease
Wei Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Gaucher disease
Terry D. Butters
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease
Kerry Anne McEachern et al.
MOLECULAR GENETICS AND METABOLISM (2007)
The fate and function of glycosphingolipid glucosylceramide
G van Meer et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES (2003)
分享论文
